Therefore, these results suggest a deeper clarification regarding bFGF expression in chemoresistant bladder cancer cells, particularly with regard to its role in bladder cancer recurrence after intravesical chemotherapy [167]. This evidence concerns the gene FGF2 and urinary bladder carcinoma.